NervGen Peptide Demonstrates Nerve Repair in Phase II SCI Trial
24 Nov 2025 //
BIOSPACE
NervGen Reports Ph1b/2a NVG-291 Data In Spinal Cord Injury
02 Jun 2025 //
GLOBENEWSWIRE
NervGen Pharma to Host Virtual Investor Event
25 Mar 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support